ArticleSurgery today2026

Early thyroid-stimulating hormone dynamics predict outcomes in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Michinori Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.